Bispecific CD3 Molecules in Oncology Analytical Tool 2018: 67 Companies Plus Partners, Developing 148 Bispecific CD3 Drugs
Dublin, Dec. 13, 2018 (GLOBE NEWSWIRE) -- The "Bispecific CD3 Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. There is a considerable and robust commercial drug pipeline of T-cell …